Lyfe Wire

What the research actually says.

Plain-English research dispatches from your companion — grounded in cited sources from MedlinePlus, PubMed, the FDA, USDA, and ClinicalTrials.gov. SkinnyLyfe doesn't make medical claims. We surface what the source says.

June 27, 2026 · Research & News
Can GLP-1 Drugs Reduce Cancer Risk? Here's What the Research Actually Shows
June 26, 2026 · Research & News
NDSU and Sanford Health Are Studying What GLP-1 Drugs Actually Do in the Real World — and That's a Big Deal
June 25, 2026 · Research & News
Noom Just Made Its GLP-1 Companion Free — Here's Why That's Worth Paying Attention To
June 24, 2026 · Research & News
AI-CGM Platform Engagement Linked to Clinically Meaningful Weight Loss
June 23, 2026 · Research & News
7 GLP-1 Side Effects to Expect, Week by Week
June 22, 2026 · Mind & Habits
Habit Formation in the Medication Era: Don't Waste the Quiet Window
June 21, 2026 · GLP-1 & Meds
Stopping Your GLP-1 Doesn't Mean Starting Over — But Here's Why the Weight Comes Back
June 20, 2026 · Mind & Habits
Your Brain Hasn't Caught Up Yet: What Research Says About Body Image During Rapid Weight Loss
June 19, 2026 · GLP-1 & Meds
Your Liver Is Quietly Winning (or Losing) While You Focus on the Scale
June 18, 2026 · Research & News
GLP-1s May Lower The Risk Of These 13 Cancers, New Study Finds
June 17, 2026 · Research & News
The Weight-Loss Drug That May Also Quiet the Brain's Rage Circuit
June 16, 2026 · Research & News
The GLP-1 Pill Era Has Officially Arrived — And Your GP Is Still Catching Up
June 15, 2026 · GLP-1 & Meds
GLP-1 Drugs and Type 2 Diabetes: What the Science Actually Says
June 14, 2026 · Mind & Habits
Prediabetes: What's Actually Happening in Your Body — and What the Research Says Changes It
June 13, 2026 · Research & News
Obesity Is a Chronic Disease — Here's How Clinicians Actually Think About It
June 12, 2026 · Research & News
A Popular GLP-1 Drug May Be Turning Back Your Biological Clock — Here's What the Science Actually Says
June 11, 2026 · Research & News
Penn Study Links GLP-1 Use to 30% Lower Breast Cancer Risk — and a Clinical Trial Is Coming
June 10, 2026 · Research & News
GLP-1 RAs May Reduce Risk of Obesity-Related Cancers — Here's What the Research Actually Shows
June 9, 2026 · Research & News
The Drug Quiets the Noise. You Still Have to Change the Station.
June 8, 2026 · Research & News
Exercise Is Medicine: A Landmark Cancer Trial and the Heart Health Case for Moving More
June 7, 2026 · Research & News
GLP-1 Drugs Linked to Fewer Heart Events in People With Obesity and Autoimmune Disease
June 6, 2026 · Research & News
Beyond GLP-1: What Amylin Analogs Could Mean for the Next Generation of Weight-Loss Drugs
June 3, 2026 · Research & News
GLP-1 Drugs May Keep You Out of the Operating Room — New Research Points to Fewer Knee Replacements
June 2, 2026 · Research & News
Study of 400,000 Reddit Posts Reveals Possible New Ozempic Side Effects — Here's What It Actually Means
June 1, 2026 · GLP-1 & Meds
Wegovy vs. Zepbound: What the FDA Labels Actually Say (and Who Each Drug Is Approved For)
May 31, 2026 · GLP-1 & Meds
Why Your GLP-1 Dose Schedule Is Designed to Go Slow — And What Happens When You Rush It
May 30, 2026 · Research & News
Lilly's Triple-Target Drug Just Hit 28% Weight Loss in a Phase 3 Trial. Here's What That Actually Means.
May 29, 2026 · Research & News
Lilly's Retatrutide Posts 28.3% Weight Loss in Phase 3 — and a Bigger Side-Effect Question
May 28, 2026 · Research & News
France's Bold Move: State Coverage for Breakthrough Obesity Drugs
May 27, 2026 · Research & News
The Phantom Link Between Weight-Loss Drugs and Suicide
May 26, 2026 · Research & News
GLP-1 Drugs Are Eating Into Bariatric Surgery — Here's What the Research Actually Says
May 25, 2026 · Research & News
AI Scanned 400,000 Reddit Posts for Ozempic Side Effects. Here's What It Found.
May 24, 2026 · Research & News
GLP-1s Are Emptying Operating Rooms. Here's What the Research Actually Says.
May 23, 2026 · Research & News
GLP-1 Drugs and Eating Disorders: Why Doctors Are Sounding the Alarm Right Now
May 22, 2026 · Research & News
14 New Weight Loss Drugs Are in the Pipeline. Here's What the Research Actually Shows.
May 21, 2026 · Research & News
Obesity Care Is Missing Where It's Needed Most — And the Data Is Getting Hard to Ignore
May 20, 2026 · Research & News
Weight Lost on GLP-1 Drugs Can Rebound After Stopping — Here's the Science Behind Why
May 19, 2026 · Mind & Habits
The Two-Way Street Between Sleep Apnea and Weight — and Why It Actually Matters
May 18, 2026 · Research & News
Your Genes May Decide How Well Weight Loss Drugs Work
May 17, 2026 · Research & News
Mounjaro Demand Keeps Surging — Here's the Clinical Story Behind the Headlines

Can GLP-1 Drugs Reduce Cancer Risk? Here's What the Research Actually Shows

NDSU and Sanford Health Are Studying What GLP-1 Drugs Actually Do in the Real World — and That's a Big Deal

Noom Just Made Its GLP-1 Companion Free — Here's Why That's Worth Paying Attention To

AI-CGM Platform Engagement Linked to Clinically Meaningful Weight Loss

7 GLP-1 Side Effects to Expect, Week by Week

Habit Formation in the Medication Era: Don't Waste the Quiet Window

Stopping Your GLP-1 Doesn't Mean Starting Over — But Here's Why the Weight Comes Back

Your Brain Hasn't Caught Up Yet: What Research Says About Body Image During Rapid Weight Loss

Your Liver Is Quietly Winning (or Losing) While You Focus on the Scale

GLP-1s May Lower The Risk Of These 13 Cancers, New Study Finds

The Weight-Loss Drug That May Also Quiet the Brain's Rage Circuit

The GLP-1 Pill Era Has Officially Arrived — And Your GP Is Still Catching Up

GLP-1 Drugs and Type 2 Diabetes: What the Science Actually Says

Prediabetes: What's Actually Happening in Your Body — and What the Research Says Changes It

Obesity Is a Chronic Disease — Here's How Clinicians Actually Think About It

A Popular GLP-1 Drug May Be Turning Back Your Biological Clock — Here's What the Science Actually Says

Penn Study Links GLP-1 Use to 30% Lower Breast Cancer Risk — and a Clinical Trial Is Coming

GLP-1 RAs May Reduce Risk of Obesity-Related Cancers — Here's What the Research Actually Shows

The Drug Quiets the Noise. You Still Have to Change the Station.

Exercise Is Medicine: A Landmark Cancer Trial and the Heart Health Case for Moving More

GLP-1 Drugs Linked to Fewer Heart Events in People With Obesity and Autoimmune Disease

Beyond GLP-1: What Amylin Analogs Could Mean for the Next Generation of Weight-Loss Drugs

GLP-1 Drugs May Keep You Out of the Operating Room — New Research Points to Fewer Knee Replacements

Study of 400,000 Reddit Posts Reveals Possible New Ozempic Side Effects — Here's What It Actually Means

Wegovy vs. Zepbound: What the FDA Labels Actually Say (and Who Each Drug Is Approved For)

Why Your GLP-1 Dose Schedule Is Designed to Go Slow — And What Happens When You Rush It

Lilly's Triple-Target Drug Just Hit 28% Weight Loss in a Phase 3 Trial. Here's What That Actually Means.

Lilly's Retatrutide Posts 28.3% Weight Loss in Phase 3 — and a Bigger Side-Effect Question

France's Bold Move: State Coverage for Breakthrough Obesity Drugs

The Phantom Link Between Weight-Loss Drugs and Suicide

GLP-1 Drugs Are Eating Into Bariatric Surgery — Here's What the Research Actually Says

AI Scanned 400,000 Reddit Posts for Ozempic Side Effects. Here's What It Found.

GLP-1s Are Emptying Operating Rooms. Here's What the Research Actually Says.

GLP-1 Drugs and Eating Disorders: Why Doctors Are Sounding the Alarm Right Now

14 New Weight Loss Drugs Are in the Pipeline. Here's What the Research Actually Shows.

Obesity Care Is Missing Where It's Needed Most — And the Data Is Getting Hard to Ignore

Weight Lost on GLP-1 Drugs Can Rebound After Stopping — Here's the Science Behind Why

The Two-Way Street Between Sleep Apnea and Weight — and Why It Actually Matters

Your Genes May Decide How Well Weight Loss Drugs Work

Mounjaro Demand Keeps Surging — Here's the Clinical Story Behind the Headlines

Plain-English research, daily